Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an AI listener write therapy notes without breaking the Doctor-Patient bond?

NCT ID NCT07777224

Knowledge-focused Sponsor: Psychiatrie St. Gallen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether an AI tool that listens to psychiatric consultations and drafts clinical notes can reduce the time clinicians spend on paperwork. It includes mental health providers and their adult patients at a Swiss psychiatric clinic. Researchers will compare clinicians using the AI to those writing notes as usual, measuring documentation time, note quality, and the patient-rated therapeutic relationship. The goal is to see if the AI can ease administrative burden without harming the quality of care or the connection between clinician and patient.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
An artificial intelligence ambient scribe that listens to consultations and drafts clinical notes
What this could lead to
If effective, this AI tool could reduce clinician burnout and free up time for patient care, while maintaining the quality of medical records and the therapeutic relationship.
What could go wrong
The trial is small and early, and the AI may not produce notes as good as those written by clinicians, or patients might feel the tool affects their connection with their provider.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

47 people

The number who actually took part.

Started

Jul 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

The observed study population comprises mental health care providers (physicians, psychologists/psychotherapists, nurses, and social workers) employed at Psychiatrie St. Gallen. Provider Inclusion Criteria: * Readiness to use an artificial intelligence ambient scribe during patient consultations (intervention group) * Regular clinical consultations with adult psychiatric patients Two outcome-specific criteria apply: contribution to the report quality outcomes requires that the provider regularly conducts new-patient intakes and writes initial psychiatric assessment reports; contribution to the patient-reported outcomes requires working in the outpatient setting. Providers who cannot or no longer wish to contribute to any actively collected outcome may, with their consent, remain enrolled for passive documentation-time measurement only; for analysis, such providers stay in the group which was fixed at enrollment.. Provider Exclusion Criteria: * notice of termination of the employment contract given during the data collection period * Working in the dementia inpatient clinic Patients are not the observed population, but anonymous ratings of their subjective consultation experience are collected from them, and written consent for the review of initial assessment reports is obtained. Patient Inclusion Criteria: \- All adult patients visiting the outpatient clinic during the data collection periods for a consultation with a participating provider Patient Exclusion Criteria: * Insufficient German proficiency (below level B2) * Cognitive impairment precluding informed participation * Acute psychosis, acute suicidality, mania, or intoxication * Severe emotional distress

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Artificial intelligence (AI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Burnout, Psychological

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Artificial intelligence (AI) Burnout Documentation Efficiency of physician documentation Empathy Quality improvement Therapeutic alliance

Contacts and locations

Locations

  • Psychiatrie St. Gallen

    Heerbrugg, Canton of St. Gallen, 9435, Switzerland

  • Psychiatrie St. Gallen

    Pfäfers Dorf, Canton of St. Gallen, 7312, Switzerland

  • Psychiatrie St. Gallen

    Rorschach, Canton of St. Gallen, 9400, Switzerland

  • Psychiatrie St. Gallen

    Sankt Gallen, Canton of St. Gallen, 9000, Switzerland

  • Psychiatrie St. Gallen

    Sargans, Canton of St. Gallen, 7320, Switzerland

  • Psychiatrie St. Gallen

    Uznach, Canton of St. Gallen, 8730, Switzerland

  • Psychiatrie St. Gallen

    Wattwil, Canton of St. Gallen, 9630, Switzerland

  • Psychiatrie St. Gallen

    Wil, Canton of St. Gallen, 9500, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.